Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - LIBERATOR MEDICAL HOLDINGS, INC. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - LIBERATOR MEDICAL HOLDINGS, INC. | v232654_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - LIBERATOR MEDICAL HOLDINGS, INC. | v232654_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - LIBERATOR MEDICAL HOLDINGS, INC. | v232654_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - LIBERATOR MEDICAL HOLDINGS, INC. | v232654_ex31-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
(Amendment No. 1)
(Mark One)
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended June 30, 2011
|
or
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from ____________ to ____________
|
Commission file number: 000-05663
LIBERATOR MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|
NEVADA
|
87-0267292
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
2979 SE Gran Park Way, Stuart, Florida 34997
(Address of principal executive offices) (Zip Code)
(772) 287-2414
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer ¨
|
Accelerated filer ¨
|
Non-accelerated filer ¨
|
Smaller reporting company þ
|
|
(Do not check if a smaller reporting company)
|
Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No þ
APPLICABLE TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
|
Class
|
Outstanding as of August 11, 2011
|
|
|
Common Stock, $.001
|
48,046,650
|
EXPLANATORY NOTE
Liberator Medical Holdings, Inc., is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the period ended June 30, 2011, as filed with the Securities and Exchange Commission on August 15, 2011, for the sole purpose of furnishing Exhibit 101 to the Form 10-Q which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included in Part 1, Item 1 of the Form 10-Q. As permitted by Rule 405(a)(2)(ii) of Regulation S-T, Exhibit 101 was required to be furnished by amendment within 30 days of the original filing date of the Form 10-Q.
No changes have been made to the Form 10-Q other than the furnishing of Exhibit 101 described above. This amendment does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way the disclosures made in the Form 10-Q.
Pursuant to Rule 406T of Regulation S-T, the Interactive Data File on Exhibit 101 hereto is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise is not subject to liability under those sections.
PART II — OTHER INFORMATION
|
Item 6. Exhibits
|
|
|
Exhibit 31.1
|
Section 302 Certificate of Chief Executive Officer
|
|
Exhibit 31.2
|
Section 302 Certificate of Chief Financial Officer
|
|
Exhibit 32.1
|
Section 906 Certificate of Chief Executive Officer
|
|
Exhibit 32.2
|
Section 906 Certificate of Chief Financial Officer
|
|
Exhibit 101
|
Interactive Data File
|
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.
|
/s/ LIBERATOR MEDICAL HOLDINGS, INC.
|
|
|
Registrant
|
|
/s/ Mark A. Libratore
|
President
|
August 26, 2011
|
||
|
Mark A. Libratore
|
||||
|
|
||||
|
/s/ Robert J. Davis
|
Chief Financial Officer
|
August 26, 2011
|
||
|
Robert J. Davis
|